Skip to main content
AIMS Microbiology logoLink to AIMS Microbiology
. 2020 Nov 17;6(4):434–450. doi: 10.3934/microbiol.2020026

Brought to you courtesy of the red, white, and blue–pigments of nontuberculous mycobacteria

Tru Tran 1, Stephanie N Dawrs 2, Grant J Norton 2, Ravleen Virdi 2, Jennifer R Honda 2,*
PMCID: PMC7755587  PMID: 33364537

Abstract

Pigments are chromophores naturally synthesized by animals, plants, and microorganisms, as well as produced synthetically for a wide variety of industries such as food, pharmaceuticals, and textiles. Bacteria produce various pigments including melanin, pyocyanin, bacteriochlorophyll, violacein, prodigiosin, and carotenoids that exert diverse biological activities as antioxidants and demonstrate anti-inflammatory, anti-cancer, and antimicrobial properties. Nontuberculous mycobacteria (NTM) include over 200 environmental and acid-fast species; some of which can cause opportunistic disease in humans. Early in the study of mycobacteriology, the vast majority of mycobacteria were not known to synthesize pigments, particularly NTM isolates of clinical significance such as the Mycobacterium avium complex (MAC) species. This paper reviews the overall understanding of microbial pigments, their applications, as well as highlights what is currently known about pigments produced by NTM, the circumstances that trigger their production, and their potential roles in NTM survival and virulence.

Keywords: Nontuberculous mycobacteria, pigment, virulence, nonchromogens, photochromogens, scotochromogens

1. Introduction

Multicolored creatures comprise the macroscopic and microscopic worlds. Elucidating the evolutionary advantages for developing particular coloration and patterns has intrigued the scientific community for centuries. Examples include the cryptic coloration of the Megascops asio eastern screech owl, aposematism in Phyllidia varicose nudibranchs, advancement of sexual selection among Paradisaea decora Goldie's bird of paradise, and protection of human and animal skin from UV radiation through the production of melanin. For photosynthesizing plants, green chlorophyll is the most widely recognized and understood pigment. Likewise, pigments derived from microbes are well-studied and often used in coloring that is added to clothing/textiles, cosmetics, and food [1]. But, for the microbes from which they are derived, pigments are diverse chemicals produced in direct response to a broad range of conditional circumstances with multifunctional biological properties and activities.

2. Bacterial pigment varieties and their functions

Empirically, bacteria produce pigments to facilitate survival in the harsh terrestrial and marine environments from which they are typically associated, including air-water interfaces, glaciers, ice cores, soil, lava caves, salt lakes, groundwater, deep sea hydrothermal vents, and hot springs [2]. Independent of photosynthesis, the functional purposes of microbial pigments are to: (i) protect against UV radiation, oxidants, extreme temperature changes, and desiccation, (ii) act as antimicrobial agents, (iii) recover nutrients, (iv), avert phagocytosis, (v) transport iron [2],[3] and (vi) promote bacterial pathogenicity and virulence (e.g., enhanced virulence of melanin-producing Vibrio cholerae by increasing cholera toxin production) [4]. In some circumstanaces, a variety of bacteria use quorum-sensing to produce pigments, including production of violacein by Chromobacterium violaceum that results from the coordinated behavior of the bacterial community [3],[5],[6].

Because molecular oxygen is required for pigment production, obligate anaerobes are typically devoid of pigment [7]. On the other hand, the aerobic Phylum Actinobacteria is composed, in part, of pigment-producing bacteria; of which Streptomyces produces a wide variety [8]. Among this phylum, certain species of acid-fast Mycobacteria are described as nonchromogenic in the dark, but become photochromogenic and produce bright orange/pink pigments upon short-wave light exposure, suggesting light influences pigment production [7]. Yet other bacteria produce a wide variety of pigments of varying colors including Serratia (red), Vibrio (red), Halobacterium (rose-pink), Allochromatium (orange-brown/pink-purple), and Thiocapsa (rosy-peach) [9].

3. Spectrum of bacterial pigments

Bacterial pigments include melanin, pyocyanin, bacteriochlorophyll, violacein, and prodigiosin; of which, carotenoids are the most widely observed and studied [10] (Figure 1). Herein, we systematically discuss each pigment in terms of its biology, source, function, applications and implications, biosynthesis and regulation, and interaction with the immune system, if known.

Figure 1. Spectrum of microbial pigments.

Figure 1.

3.1. Melanin

Biology: A negatively charged, hydrophobic, high molecular weight chromophore composed of polymerized phenolic or indolic, dark-colored natural pigments (e.g., black/brown eumelanins, red/yellow pheomelanins, and dark brown-black allomelanins). Source: Melanin is typically produced by organisms across many kingdoms as well as marine bacteria including Vibrio cholerae and Proteus mirabilis [11]. Function: Melanin is critical to the bacteria that synthesize it because it provides an innate shield against solar radiation, desiccation, toxic heavy metals, oxidative stress, and hyperosmotic shock [11]. For example, to survive extreme aquatic marine habitats, Shewanella uses melanin as a terminal electron acceptor during shifts between aerobic and anaerobic respiration, particularly when environmental oxygen is scarce [12]. Separately, Legionella pneumophila melanin is used to increase iron availability during iron-limiting conditions by reducing Fe3+ to bioavailable Fe2+ [13]. Application: Melanin has been developed to increase the sun protection factor in sunscreens, biocontrol, and in the industrial production of light-stable, environmental friendly insecticides [14]. Biosynthesis and regulation: Most of the bacterial melanins are formed through multi-process transformations of aromatic compounds involving the amino acids methionine and tyrosine using similar biochemical processes in humans. In bacteria such as Sinorhizobium meliloti, the trxL gene codes for thioredoxin, which stimulates tyrosinase activity needed for chromophore production [15]. Other bacteria including Escherichia coli, Pseudomonas putida, Cornybacterium glutamicum, and Streptomyces griseus synthesize melanin from malonyl-CoA catalyzed by polyketide synthases [14],[16]. In several species of Streptomyces, the polyketide synthase RppA responsible for melanin synthesis, is regulated by transcriptional regulator AdpA that also controls sporulation processes [15],[17],[18]. In addition to polyketide synthases, other diverse enzymes, substrates, and multiple pathways are used to regulate the synthesis of bacterial melanin such as temperature, nutritional factors (e.g., copper, zinc, nitrogen, and oxygen), or stress as observed for the seawater bacterium Marinomonas mediterranea [14]. Interaction with the immune system: Melanin increases bacterial virulence by reducing susceptibility to host defense mechanisms and by influencing the host immune responses to infection [11]. For example, Burkholderia cepacia melanin acts as an antioxidant, attenuating macrophage superoxide production [19]. To protect against oxidative stress, melanin from Burkholderia cenocepacia neutralizes reactive oxygen species (ROS) generated by the oxidative burst in host cells [20]. Melanin from V. cholerae increases ROS production, toxin and pilus expression, as well as enhances host colonization and protection from amoeba predation [4],[21]. During chronic infections, Pseudomonas aeruginosa increases melanin production to resist oxidative stress [14].

3.2. Pyocyanin

Biology and source: A zwitterion, water soluble pigment canonically produced by P. aeruginosa and is one of the most widely characterized bacterial virulence factors with antimicrobial and anti-inflammatory properties [22]. Jayaseelan et al., provides a comprehensive review of pyocyanin biology [23]. Briefly, pyocyanin's most widely recognized characteristic is its secreted blue-green color, commonly observed in sputa from P. aeruginosa-infected patients [24]. Function: Pyocyanin shows oxidase activity and inhibits the growth of other competitors while easily penetrating biological membranes [25]. Application: Because of its distinct color, pyocyanin is used as a coloring agent for clothes made of cotton and linen and in food coloring [26]. It also has the capacity to degrade pesticides, and inhibits fungal growth by arresting the electron transport chain [27],[28]. Biosynthesis and regulation: A variety of studies have suggested cell-density dependent quorum sensing autoinducers control many of the known virulence factors of P. aeruginosa, including pyocyanin production [29]. Pyocyanin production is regulated by two copies of a seven-gene operon that synthsize phenazine-1-carboxylic acid which is converted to pyocyanin by two additional modifying enzymes, an adenosylmethionine dependent methyltransferase (phzM) and a flavin dependent hydroxylase (phzS) [30],[31]. The synthesis of pyocyanin by P. aeruginosa is also strongly dependent on natural nutrients such as carbohydrates, fats, proteins, peptones, magnesium chloride, and glycerol. In the absence of these factors, bacterial density and pyocyanin pigment concentration are greatly reduced [32],[33]. Interaction with the immune system: In the human airway, pyocyanin oxidizes glutathione and NADH resulting in increased ROS (e.g., H2O2) [34], redox homeostasis disturbance, and epithelial cell injury and death [35]. Importantly, P. aeruginosa mutants lacking pyocyanin show attenuation in both acute and chronic mouse models of lung infection [25]. As a virulence factor, pyocyanin reduces bacterial clearance from the lungs by accelerating the clearance of neutrophils from inflamed sites via apoptosis [36].

3.3. Bacteriochlorophyll (BChl)

Biology: Pigments such a chlorophyll are employed by photosynthetic organisms such as plants and certain bacteria by harvesting energy from sunlight. There are several different chlorophyll pigments, each with different stereochemistry, esterifying alcohol, methylation, and light-harvesting efficiency due to their distinctive absorption characteristics. Source: Phototrophic bacteria (e.g., purple bacteria, green sulfur bacteria, Heliobacteria) produce the photosynthetic pigment BChl, which encompasses pigments BChla-BChlg to conduct photosynthesis, but does not generate oxygen as a byproduct [37]. Typically, BChl-producing phototrophic bacteria are facultative, obligate anaerobes or obligate aerobic bacteria [37]. There are two main groups of purple bacteria - those that produce BChl anaerobically in the light and dark (e.g., Rhodobacter spharoides, Rhodobacter capsulatus, Rhodobacter rubrum) and those that synthesize BChl under both anaerobic and aerobic conditions in the light (e.g., Rhodovulum sulfidophilum, Roseobacter sp., Rubrivivax gelatinosus) [38]. Function: As strict anaerobes, green sulfur bacteria perform phototrophic processes without the production of oxygen and use reduced sulfur compounds as electron donors. They also produce chlorosomes, specialized antenna complexes that contain high concentrations of BChl c, d, or e [39]. Application: Because of its photochemistry and light harvesting properties, BChl has been studied as a potential sensitizer in photodynamic therapy aimed to target tumor cells [40],[41]. Biosynthesis and regulation: Through numerous studies aimed to understand differences in BChl expression and production under varying environmental conditions, the biosynthetic pathways of BChl have been identified [37],[39],[42],[43]. However, the exact role of each individual BChl on bacterial metabolism and survival has yet to be elucidated. Interaction with the immune system: Currently, the role of BChl in modulating the host immune response in human is ill-defined.

3.4. Violacein

Biology and source: A water-soluble violet/purple pigment produced by diverse bacterial genera such as Pseudoalteromonas, Cillimonas, Duganella, and Janthinobacterium; of which, Chromobacterium violaceum is the most well-known [44]. Gram-negative C. violaceum is typically found in tropical water and soil and was first isolated from the Amazon River [45]. Function: Violacein provides protection from UV radiation and protozoal predation, shields the bacterial lipid membrane from peroxidation caused by hydroxyl radicals, and induces apoptosis of leukocyte cell lines [46][50]. Additionally, violacein demonstrates antibacterial activity against Gram-positive and Gram-negative bacteria, particularly Staphylococcus aureus [51],[52] and Escherichia coli (>50 mg/L) [51]. Violacein also exerts antimicrobial activity against protozoans and metazoans [49]. For example, Acanthamoeba castellanii exhibits markers of cell death including decreased feeding, cell rounding, and increased caspase-3-like activity with violacein exposure [53]. Application: It has been suggested that violacein demonstrates anti-cancer properties. For example, introducing violacein into colorectal cell line Caco-2 mediates production of ROS, resulting in damage to mitochondrial membranes, leakage of cytochrome c, and cell death via apoptosis as the result of caspase-3 activation [54]. Biosynthesis and regulation: The biosynthesis pathway of violacein begins with L-tryptophan as a substrate that is sequentially processed by five different enzymes encoded by five different genes: vioA, vioB, vioC, vioD, and vioE [55]. Interaction with the immune system: In the HL60 myeloid leukemia cancer cell line, violacein induced apoptosis at half maximal inhibitory concentration (700 nM), but this could not be recapitulated in other types of leukemia cells, human leukocytes, and monocytes [47]. The anti-cancer mechanism of violacein appears to mimic the activities of tumor necrosis factor α (TNF-α) in signaling cellular apoptosis through the activation of caspase 8, transcription of nuclear factor kappaB (NF-κB), and p38 mitogen-activated protein (MAP) kinase [47].

3.5. Prodigiosin

Biology and source: A light-sensitive, alcohol-soluble, red-pigment produced by various Gram-negative bacteria including Serratia marcescens and Streptomyces spp. Prodigiosin derivatives have also been identified in the marine γ-proteobacterium, Pseudoalteromonas [56]. Function: Vibrio producing prodigiosin show increased survival against UV exposure compared to non-prodigiosin-producing Vibrio isolates, suggesting a role of protection in the environment [57]. Similar to other pigments discussed, prodigiosin exerts antimicrobial activity. Purified prodigiosin from Vibrio demonstrates bacteriostatic properties against Staphylococcus, Streptococcus, and Klebsiella, although its mechanism of action remains poorly understood [58]. Prodigiosin also demonstrates activity against chloroquine-resistant strain Plasmodium falciparum, induces synthesis of autolysins in Bacillus cereus, and stimulates production of ROS that prevents formation of biofilm in P. aeruginosa [56],[59]. In the case of herpes simplex virus type 1 and 2, prodigiosin exerts antiviral activity by inhibiting NF-κB and Akt signaling pathways in vitro and ex vivo in cultured porcine corneas [60]. The pathway in which prodigiosin provides antiviral relief involves the inhibition of anti-apoptotic activity of TNF-α mediated by NF-κB [60]. Applications: Prodigiosin has been used in food coloration to replace the synthetic pigments used in the food industry, coloration of polyolefines, as well as applied in sunscreen to increase the sunscreen protection factor [61]. Biosynthesis and regulation: Biosynthesis of prodigiosin is regulated by PigP—a master transcriptional regulator of multiple genes involved in production of prodigiosin [62]. Mutations in PigS, a member of PigP regulon, resulted in reduced production of prodigiosin by decreasing the transcription of the biosynthetic operon [62]. Pseudoalteromonas also synthesizes other analogs of prodigiosin including cycloprodigiosin (cPrG) and 2-(p-hydroxybenzyl) prodigiosin (HBPG). The key difference in structure between prodigiosin and cPrG is the cyclization between the C-3 pentyl group and C-4 on pyrrole ring C of 2-methyl-3-n-amyl-pyrrole. HBPG differs in structure to prodigiosin by the para-addition of phenol to C-10 of the pyrrole ring A of 4-methoxy-2,2′-bipyrrole-5-carbaldehyde [56]. Interaction with the immune system: Prodigiosin shows immunosuppressive properties by inhibiting both T-cell receptor dependent and independent proliferation of T-cells [3],[63]. Additionally, S. marcescens prodigiosin induces apoptosis in hematopoietic cancer and human colon cancer cell lines [64]. Other novel activities attributed to prodigiosin include negatively altering biofilm integrity of P. aeruginosa and H2O2 and hydroxyl radicals stimulated by prodigiosin show strong cleaving properties towards DNA and RNA, but no effect on protein [65]. Pseudoalteromonas cPrG was shown induce apoptosis in several cancers including acute human T-cell leukemia, acute promyelocytic leukemia, human and rat hepatocellular cancer, human breast cancer, and TNF-stimulated human cervix carcinoma [56],[61].

3.6. Carotenoid

Biology and source: Lipid soluble, yellow-orange-red-pink [66] colored organic, natural pigments widely observed in bacteria, but also found in plants, algae, and fungi [67]. The carotenoid pigments typified for bacteria include orange-pink canthaxanthin, echinenone pigments of Micrococcus roseus, red astaxanthin pigments of marine bacteria such as Halobacterium spp., and the orange-staphyloxanathin membrane bound pigments of S. aureus [68]. Function: Bacterial carotenoids shield against UV radiation and oxidative damage and facilitate membrane fluidity that promote viability at low temperatures and facilitate nutrient transport [69],[70]. S. aureus carotenoids are necessary and sufficient to promote its pathogenicity. Specifically, loss of staphyloxanathin significantly decreases the virulence of S. aureus in murine skin abscesses or systemic models of infection and its production by group A Streptococcus results in large skin lesions in mice [71]. Carotenoids are extremely hydrophobic and are used to stabilize bacterial membranes while being described as antioxidant agents [9]. For example, xanthomodanin exhibits antioxidant properties by inhibiting photodynamic lipid peroxidation in liposomes to protect against photodamage [72]. Carotenoids of Antarctic heterotrophic bacteria facilitate adaptation to harsh and cold environments by modulating their membrane fluidity under a wide range of temperatures [73]. Application: Carotenoids are used in food products in solution or suspension in vegetable oils and to color margarine [9]. As a potential biologic in medicine, the carotenoids derived from the soil-dwelling Kocuria rhizophila and Corynebacterium glutamicum demonstrate antimicrobial activity against the nematode Caenorhabditis elegans [74]. Holomonas sp.-derived carotenoids demonstrate broad antimicrobial activities against Klebsiella, Pseudomonas, and Staphylococcus, but also anti-cancer properties [75]. Biosynthesis and regulation: Carotenoid synthesis begins with a 5-carbon building block isopentenyl pyrophosphate followed by chain elongation catalyzed by prenyl transferases that synthesize geranyl, farnesyl, or geranylgeranyl pyrophosphate–all of which are precursors of carotenoids [76]. Interaction with the immune system: Carotenoids have been demonstrated to play several key immune functions such as stimulating production of immunoglobulin production by B cells, as well as increasing the sensitivity and activity of CD4+ helper T cells, CD8+ cytotoxic T cells, and natural killer cells against viruses, bacteria, parasites, and fungi [77]. In addition evidence suggests dietery β-carotene prevents bladder, kidney, ear, and gut infections in rats with vitamin A deficiency, and reduced ear infections in children [77]. Carotenoids also exhibit anti-cancer effects on various cancer cell lines such as esophagus, breast, liver, and cervix [78].

4. Environmental factors that influence bacterial pigment production

Summarized above are the varieties and biological summaries of six well-described bacterial pigments. Stimulation of pigment production is driven by a myriad of factors including nutitional factors and varying environmental conditions as highlighted in Table 1.

Table 1. Environmental factors that influence pigment production.

Environmental factor Promote or inhibit pigment production Genus, species Reference
Nutritional factors
Nutrient-rich conditions Promote Flexibacter elegans [79]
High availability of phosphate Inhibition of fluorescent pigment Flexibacter elegans [79]
Trace sulfate Promote Flexibacter elegans [79]
Methanol as a carbon source Promote pink pigment production Acinetobacter wofii,
Methylobacterium extorquens
[80]
[66]
Succinate as a carbon source Promote yellow-green fluorescent pigment Pseudomonas fluorescens [81]
Presence of copper Promote prodigiosin Serratia marcescens [65]
Low iron Promote carotenoids Synechococcus species [82]
Nicotine Inhibit carotenoids Mycobacterium marinum [83]
Environmental conditions
High acidity Inhibition of fluorescent pigment Flexibacter elegans [79]
Promote carotenoids Mycobacterium smegmatis [84]
Production of carotenoids Mycobacterium tuberculosis [85]
Hyperosmotic stress Production of melanin Vibrio cholera [86]
Nutrient-rich conditions Promote Flexibacter elegans [79]
High availability of phosphate Inhibition of fluorescent pigment Flexibacter elegans [79]

5. Spotlighting the current knowledge of mycobacterial pigments

Presently, the Mycobacterium genus consists of over 200 recognized species [87], of which Mycobacterium tuberculosis (tuberculosis) and Mycobacterium leprae (leprosy) are the most widely recognized. However, the majority of the genus is comprised of nontuberculous mycobacteria (NTM), of which, a subset can cause environmentally acquired opportunistic pulmonary and skin disease of varying severity in susceptible individuals. The majority of the NTM do not produce pigment; however, some are known to synthesize yellow, orange, or rust colored colonies [88]. Whether the pigment is visible by the naked eye or by visualization under a microscope depends on its concentration within an organism [89].

Of the bacterial pigments discussed earlier in this review, carotenoids are the most well-characterized pigments of NTM, functioning as free radical scavengers to protect against oxidative stress [89]. Using thin-layer chromatography, Tarnok et al. elucidated the carotenoids of Mycobacterium phlei (xanthophyls), M. avium, M. kansasii (alpha and beta-carotene and lycopene), M. intracellulare, M. aurum, M. marinum, M. gordonae, and M. scrofulcaceum [89],[90]. Carotenoid gene regulation in NTM has also been studied in some detail. The crt gene cluster has been shown to encode for enzymes responsible for the synthesis of crtB, crtE, crtl, and crtY carotenes in mycobacteria. When the crtB gene for yellow pigment production is transferred via cosmid from photochromogenic M. marinum into nonchromogenic M. smegmatis, yellow M. smegmatis colonies are produced [91]. However, M. smegmatis possesses other genes such as sigF which is also involved in biosynthesis of carotenoids [92]. Interestingly, the sigF sequences in M. smegmatis are highly similar to M. tuberculosis, which canonically regulate the structure and function of the mycobacterial cell wall [92]. sigF mutant knockouts are more sensitive to H2O2, oxidative stress, and show decreased transformation efficiency [92],[93]. But besides its biological effects against oxidative stress, the role of carotenoids in mycobacterial virulence remains ill-defined.

In 1959, Ernest Runyon introduced the Runyon classification scheme to classify Mycobacteria based on their rate of growth, colony morphology, and production of pigment in the presence or absence of light [94]. Besides the nonchromogenic category which include the M. avium complex (‘MAC’, such as M. avium, M. intracellulare, M. chimaera), M. terrae complex, M. ulcerans, M. xenopi, M. simiae, M. malmoense, M. asiaticum, M. haemophilum, NTM are also classified as photochromogens (colorless colonies in the dark, but synthesize pigments upon light exposure) and include M. kansasii, M. marinum, M. szulgai or scotochromogens (produce pigments in both light and dark conditions) such as M. gordonae and M. scrofulaceum. Today, the Runyon classification system is considered to be outdated due to advances in mycobacteriology [95], but also because some bacteria previously thought to be nonchromogens actually express some levels of pigmentation. For example, the MAC species were originally classified as non-pigmented, but MAC isolates from acquired immunodeficiency syndrome (AIDS) patients were later discovered to synthesize pigments [96].

MAC consists of 12 validly published species [97] including M. chimaera, M. avium, and M. intracellulare and are typically classified as nonchromogenic, showing non-pigmented colonies on Middlebrook 7H10 agar plates. MAC species typify slow-growing mycobacteria (SGM) with culture times > 14 days and are readily recovered by microbiological culture from soil and freshwater systems [98]. Currently, there is little existing knowledge regarding the biology and significance of pigment among the mycobacteria. Of interest, Methylobacterium sp. are Gram-negative α-proteobacteria, pink-pigmented facultative methylotrophs that use methanol as an energy source. Similar to NTM, Methylobacterium sp. also inhabit water distribution systems and form biofilms and produce pink carotenoids (e.g., Methylobacterium extorquens) [66]. Studies have suggested that Methylobacterium sp. is an indicator for the presence or absence of NTM [99] and Methylobacterium sp. inhibit the development of M. abscessus, M. chelonae, and M. fortuitum biofilms [100]. Whether the relationship between nonchromogenic NTM and other pink environmental bacteria such as Methylobacterium sp. is fortuitous or detrimental remains to be elucidated.

To understand the role and significance of pigments in NTM biology and the reasons and circumstances for mycobacterial pigment production, we highlight and revisit existing knowledge on this topic below.

6. Factors that promote the production of mycobacterial pigments

In 1938, sunlight, UV light, and ambient light from a 100-watt lamp were factors found to influence pigment production among unidentified pathogenic acid-fast organism found in the tropical platyfish (Platypoecilus masculatus) [7]. Acid-fast cultures incubated in the dark were colorless, whereas those incubated in presence of sunlight or UV light developed a deep orange color. Furthermore, data obtained from the same study suggested shorter light rays induced higher production of pigments in these organisms whereas full coloration resulted after 15 minutes exposure to sunlight, 30 minutes with ambient light, and one minute with UV light. It is noteworthy that prolonged exposure was lethal as demonstrated by cessation of pigmentation and unobtainable subculture post exposure [7]. Baker et al. went on to show that of 185 acid-fast isolates tested, 24 (13%) produced pigment when exposed to light [7]. Of the 24 isolates, two (8%) were colorless when grown in the dark that became light orange when exposed to light, of which, one was identified as ‘M. avium type strain.’ The remaining 22 isolates (92%) produced modest light orange when cultured in the dark and brilliant orange pigment in diffuse daylight, suggesting UV light exposure is an inducer of pigment. UV-mediated production of pigment is also dependent on bacterial viability, as only live M. marinum synthesized pigments upon UV exposure; dead M. marinum remained non-pigmented [7]. To protect from UV radiation, mycobacteria including M. tuberculosis, M. fortuitum, M. avium, M. intracellulare, M. marinum, M. kansasii, M. smegmatis, and M. flavescens show an inverse correlation between UV sensitivity and the presence of carotenes; that is, the higher the concentration of carotene present, the less sensitive the mycobacterium to UV exposure [101].

6.1. Storage time, length of incubation, and incubation temperature

In 1970, Gordon and Pang reported an isolate of M. fortuitum, originally described as non-pigmented, appeared to produce a black soluble pigment after 10 years of storage at 4 °C, indicating that extended time in storage facilitates pigment production [102]. Additionally, extended incubation time can also drive pigment production. RGM M. goodii can cause post-traumatic wound infections including osteomyelitis, producing smooth to mucoid, off-white to cream colonies in 2–4 days that turn yellow-orange after 10–15 days of incubation [103]. Smooth SGM M. colombiense produces yellow pigments with increased age (after a 4–5 weeks of incubation) [104]. Of interest, rough M. colombiense isolates lacking pigment exhibited impaired sliding motility, biofilm formation, and production of glycopeptidolipids, reducing the organism's ability to survive and invade host cells [104]. The brown-black pigment produced by M. magertense isolated from blood cultures from patients with prosthetic valve endocarditis was shown to be driven by incubation temperature. At 42 °C, M. magertense did not produce pigments. However, at 35 °C light-brown pigmented colonies appeared and even darker brown pigmented colonies were observed after seven days of incubation at 30 °C [105].

6.2. Media used for culture

Pigment production by mycobacteria may also be driven by the type of culture media used for colony observation. In 1975, the pigment intensity of M. fortuitum was described for three microbiological culture media: (1) Middlebrook 7H10, (2) Lowenstein-Jensen (L–J), and (3) American Trudeau Society (ATS) culture media [106]. At day 3 post-inoculation, no growth was observed after incubation at 25 °C, but buff colored M. fortuitum colonies were noted after incubation at 36 °C on all three media types. By day 21, rust, brown, and tan colonies with scattering of brown colonies were respectively observed on 7H10, L–J, and ATS plates incubated at 25 °C. Plates that were incubated at 36 °C showed darker brown and intense brown colonies on 7H10 and L–J plates while the same tan/brown colonies were observed on ATS plates. Although outdated now, this study demonstrated two key points. Of the three media types, darker pigmented M. fortuitum colonies were more frequently observed for L–J media compared to 7H10 and ATS media and pigmented colonies can darken with higher incubation temperature and prolonged incubation time.

6.3. Immunodeficiency and susceptibility to antibiotics

A significant percentage of patients with AIDS in the 1980's showed fatal infections caused by disseminated, nonchromogenic M. avium and M. intracellulare infection [96]. In contrast to same strains recovered from patients without AIDS, M. avium and M. intracellulare from AIDS patients showed deep, yellow carotenoid pigment producing colonies. These pigmented variants were also less tolerant to antibiotics such as β-lactams, more hydrophobic, and showed faster growth rates compared to non-pigmented variants [107]. Yet another study demonstrated that MAC isolated from 30 patients with acquired immune deficiency syndrome (86%) produced a deep yellow pigmented colonies, which remained susceptible to clofazimine, cycloserine, and ansacmycin, but resistant to isoniazid, streptomycin, ethambutol, ethionamide, and rifampin [96].

6.4. Acid exposure

NTM are found in exogenous and endogenous environments where exposure to acid fluctuates greatly. For example, NTM thrive in environments rich in humic and fluvic acids, acidic soil, and acidic brown water swamps [108][110]. NTM also resist exposure to the acidic condition of the stomach [111] and replicate in airway epithelial cells under pH 4 and 2 conditions [112]. Additionally, pH ranges between 4.5 to 6.5 are encountered by NTM the phagolysosomes of infected macrophages [84].

To study the role of acid exposure on the production of pigments by NTM in vitro, M. smegmatis was gradually induced to produce pigments by acidifying Sauton's media cultures to pH 6.0 [113]. As a result, the bacteria accumulated a dark brown fluorescent pigment noticeable in both cells and the culture medium. By studying the pigment's absorption spectra, a class of porphyrins involved in heme metabolism were identified that also served as antioxidants, providing protection against ROS. In another study, M. abscessus, M. fortuitum, M. smegmatis, M. chelonae, M. goodii, M. intracellulare, and M. avium were patched onto agar media of varying pH [84]. At pH 7, no pigments were observed from any of the tested species. At pH 6, yellow-orange pigment was reported for M. smegmatis and M. goodii. At pH 5.5, M. intracellulare, M. avium, M. abscessus, and M. chelonae produced pigments while pigmentation was maintained in M. smegmatis and M. goodii. Only two species were tested at pH 5, of which only M. abscessus continued to produce yellow-orange pigment but not M. chelonae, suggesting acid exposures modulate pigment production. Finally, M. avium subsp. paratuberculosis (MAP) is responsible for paratuberculosis in ruminants and is a potential pathogen associated with inflammatory bowel diseases in humans [114]. MAP consists of two main types, S (sheep) and C (cattle) (91). Of the two types, type S is well-known to produce yellow pigments, but not type C. However, carotenoid production for MAP type C was stimulated when the culture was grown aerobically in the media with pH below 5.5 [115].

In conclusions, the primary drivers for mycobacterial pigment production described to date are tallied in Table 2.

Table 2. Circumstances that promote pigment production in NTM.

Circumstance Date of discovery Example Reference
Light wavelength 1937 M. avium type strain [7]
Extended time in storage at 4 °C 1970 M. fortuitum [102]
Extended incubation time 1999 M. goodii [103]
Incubation temperature 2015 M. magertense [105]
Media used for culture 1976 M. fortuitum [106]
AIDS 1985 MAC [96]
Acidifying culture media 2016 M. smegmatis [113]

7. Conclusion

Bacterial pigments were first discovered and discussed more than 100 years ago; yet, their roles in mycobacterial virulence are undisputedly uncharacterized. Mycobacterial pigments are associated with photoreception and survival; but their synthesis, regulation, and physiological role have not been studied at large. In fact, most studies performed are now considered antiquated and outdated. However, the possibility that NTM may acquire pigment producing genes from other typically pigmented non-NTM bacteria within a shared environment may be a new area of exploration. Understanding the role for pigments in NTM biology could potentially open up new research opportunities that might lead to new therapeutic interventions. As an example, one of the enzymatic steps involved staphyloxanthin (a carotenoid pigment and virulence factor of S. aureus against ROS from host cells) synthesis has been found to resemble those for cholesterol synthesis. Thus, cholesterol-lowering drugs such as statins have been applied to therapeutically decrease production and activity of this virulence factor leading to increased killing of S. aureus by host cells [116]. Perhaps similar strategies may be applicable for targeted chemotherapy against NTM, providing alternative new therapies against NTM infections that are difficult to treat. Until then, we advocate for more studies to elucidate the role of pigments in the biology of mycobacterial organisms.

Acknowledgments

J.R.H. acknowledges support from the Padosi Foundation. The funders had no role in the study design, data collection and interpretation, or the decision to submit the work for publication.

Footnotes

Conflict of interest: All authors declare no conflicts of interest in this paper.

Reference

  • 1.Tuli HS, Chaudhary P, Beniwal V, et al. Microbial pigments as natural color sources: current trends and future perspectives. J Food Sci Technol. 2015;52:4669–4678. doi: 10.1007/s13197-014-1601-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ramesh C, Vinithkumar NV, Kirubagaran R, et al. Multifaceted applications of microbial pigments: current knowledge, challenges and future directions for public health implications. Microorganisms. 2019;7 doi: 10.3390/microorganisms7070186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kothari V, Joshi C, Patel P. Colourful side of bacteriology: the pigmented bacteria. Adv Genet Eng. 2016;5 [Google Scholar]
  • 4.Valeru SP, Rompikuntal PK, Ishikawa T, et al. Role of melanin pigment in expression of Vibrio cholerae virulence factors. Infect Immun. 2009;77:935–942. doi: 10.1128/IAI.00929-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gonzalez JE, Keshavan ND. Messing with bacterial quorum sensing. Microbiol Mol Biol Rev. 2006;70:859–875. doi: 10.1128/MMBR.00002-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Devescovi G, Kojic M, Covaceuszach S, et al. Negative regulation of violacein biosynthesis in Chromobacterium violaceum. Front Microbiol. 2017;8:349. doi: 10.3389/fmicb.2017.00349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Baker JA. Light as a factor in the production of pigment by certain bacteria. J Bacteriol. 1938;35:625–631. doi: 10.1128/jb.35.6.625-631.1938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lin YB, Wang XY, Fang H, et al. Streptomyces shaanxiensis sp. nov., a blue pigment-producing streptomycete from sewage irrigation soil. Int J Syst Evol Microbiol. 2012;62:1725–1730. doi: 10.1099/ijs.0.029959-0. [DOI] [PubMed] [Google Scholar]
  • 9.Kirti K, Amita S, Priti S, et al. Colorful world of microbes: carotenoids and their applications. Adv Biol. 2014;2014:1–13. [Google Scholar]
  • 10.Azmana AS, Mawangb CI, Abubakara S. Bacterial pigments: the bioactivities and as an alternative for therapeutic applications. Nat Prod Commun. 2018;13:1747–1754. [Google Scholar]
  • 11.Nosanchuk JD, Casadevall A. Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob Agents Chemother. 2006;50:3519–3528. doi: 10.1128/AAC.00545-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Turick CE, Beliaev AS, Zakrajsek BA, et al. The role of 4-hydroxyphenylpyruvate dioxygenase in enhancement of solid-phase electron transfer by Shewanella oneidensis MR-1. FEMS Microbiol Ecol. 2009;68:223–225. doi: 10.1111/j.1574-6941.2009.00670.x. [DOI] [PubMed] [Google Scholar]
  • 13.Zheng H, Chatfield CH, Liles MR, et al. Secreted pyomelanin of Legionella pneumophila promotes bacterial iron uptake and growth under iron-limiting conditions. Infect Immun. 2013;81:4182–4191. doi: 10.1128/IAI.00858-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Pavan ME, Lopez NI, Pettinari MJ. Melanin biosynthesis in bacteria, regulation and production perspectives. Appl Microbiol Biotechnol. 2020;104:1357–1370. doi: 10.1007/s00253-019-10245-y. [DOI] [PubMed] [Google Scholar]
  • 15.Castro-Sowinski S, Matan O, Bonafede P, et al. A thioredoxin of Sinorhizobium meliloti CE52G is required for melanin production and symbiotic nitrogen fixation. Mol Plant Microbe Interact. 2007;20:986–993. doi: 10.1094/MPMI-20-8-0986. [DOI] [PubMed] [Google Scholar]
  • 16.Yang D, Kim WJ, Yoo SM, et al. Repurposing type III polyketide synthase as a malonyl-CoA biosensor for metabolic engineering in bacteria. Proc Natl Acad Sci USA. 2018;115:9835–9844. doi: 10.1073/pnas.1808567115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ikeda K, Masujima T, Sugiyama M. Effects of methionine and Cu2+ on the expression of tyrosinase activity in Streptomyces castaneoglobisporus. J Biochem. 1996;120:1141–1145. doi: 10.1093/oxfordjournals.jbchem.a021533. [DOI] [PubMed] [Google Scholar]
  • 18.Zhu D, He X, Zhou X, et al. Expression of the melC operon in several Streptomyces strains is positively regulated by AdpA, an AraC family transcriptional regulator involved in morphological development in Streptomyces coelicolor. J Bacteriol. 2005;187:3180–3187. doi: 10.1128/JB.187.9.3180-3187.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Zughaier SM, Ryley HC, Jackson SK. A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion. Infect Immun. 1999;67:908–913. doi: 10.1128/iai.67.2.908-913.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Keith KE, Killip L, He P, et al. Burkholderia cenocepacia C5424 produces a pigment with antioxidant properties using a homogentisate intermediate. J Bacteriol. 2007;189:9057–9065. doi: 10.1128/JB.00436-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Noorian P, Hu J, Chen Z, et al. Pyomelanin produced by Vibrio cholerae confers resistance to predation by Acanthamoeba castellanii. FEMS Microbiol Ecol. 2017;93 doi: 10.1093/femsec/fix147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.El-Fouly MZ SA, Shahin AAM, El-Bialy HA, et al. Biosynthesis of pyocyanin pigment by Pseudomonas aeruginosa. J Radiat Res Appl Sci. 2015;8:36–48. [Google Scholar]
  • 23.Jayaseelan S, Ramaswamy D, Dharmaraj S. Pyocyanin: production, applications, challenges and new insights. World J Microbiol Biotechnol. 2014;30:1159–1168. doi: 10.1007/s11274-013-1552-5. [DOI] [PubMed] [Google Scholar]
  • 24.Price-Whelan A, Dietrich LE, Newman DK. Pyocyanin alters redox homeostasis and carbon flux through central metabolic pathways in Pseudomonas aeruginosa PA14. J Bacteriol. 2007;189:6372–6381. doi: 10.1128/JB.00505-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lau GW, Ran H, Kong F, et al. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun. 2004;72:4275–4278. doi: 10.1128/IAI.72.7.4275-4278.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Saha S, Thavasi R, Jayalakshmi S. Phenazine pigments from Pseudomonas aeruginosa and their application as antibacterial agent and food colourants. Res J Microbiol. 2008;3:122–128. [Google Scholar]
  • 27.Satapute PK, Kaliwal B. Biodegradation of the fungicide propiconazole by Pseudomonas aeruginosa PS-4 strain isolated from a paddy soil. Ann Microbiol. 2016;66:1355–1365. [Google Scholar]
  • 28.Kavitha K, Mathiyazhagan S, Sendhilvel V, et al. Broad spectrum action of phenazine against active and dormant structures of fungal pathogens and root knot nematode. Arch Phytopathol Plant Prot. 2007;38:69–76. [Google Scholar]
  • 29.Winstanley C, Fothergill JL. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. FEMS Microbiol Lett. 2009;290:1–9. doi: 10.1111/j.1574-6968.2008.01394.x. [DOI] [PubMed] [Google Scholar]
  • 30.Mavrodi DV, Bonsall RF, Delaney SM, et al. Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1. J Bacteriol. 2001;183:6454–6465. doi: 10.1128/JB.183.21.6454-6465.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Greenhagen BT, Shi K, Robinson H, et al. Crystal structure of the pyocyanin biosynthetic protein PhzS. Biochemistry. 2008;47:5281–5289. doi: 10.1021/bi702480t. [DOI] [PubMed] [Google Scholar]
  • 32.DeBritto S, Gajbar TD, Satapute P, et al. Isolation and characterization of nutrient dependent pyocyanin from Pseudomonas aeruginosa and its dye and agrochemical properties. Sci Rep. 2020;10:1542. doi: 10.1038/s41598-020-58335-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Devnath P, Uddin K, Ahamed F, et al. Extraction, purification and characterization of pyocyanin produced by Pseudomonas aeruginosa and evaluation for its antimicrobial activity. Int Res J Biol Sci. 2017;6:1–9. [Google Scholar]
  • 34.Castaneda-Tamez P, Ramirez-Peris J, Perez-Velazquez J, et al. Pyocyanin restricts social cheating in Pseudomonas aeruginosa. Front Microbiol. 2018;9:1348. doi: 10.3389/fmicb.2018.01348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Price-Whelan A, Dietrich LE, Newman DK. Rethinking ‘secondary’ metabolism: physiological roles for phenazine antibiotics. Nat Chem Biol. 2006;2:71–78. doi: 10.1038/nchembio764. [DOI] [PubMed] [Google Scholar]
  • 36.Allen L, Dockrell DH, Pattery T, et al. Pyocyanin production by Pseudomonas aeruginosa induces neutrophil apoptosis and impairs neutrophil-mediated host defenses in vivo. J Immunol. 2005;174:3643–3649. doi: 10.4049/jimmunol.174.6.3643. [DOI] [PubMed] [Google Scholar]
  • 37.Hiraishi A, Shimada K. Aerobic anoxygenic photosynthetic bacteria with zinc-bacteriochlorophyll. J Gen Appl Microbiol. 2001;47:161–180. doi: 10.2323/jgam.47.161. [DOI] [PubMed] [Google Scholar]
  • 38.Willows RD, Kriegel AM. The Purple Phototrophic Bacteria. In: Hunter C.N.DF, Thurnauer M.C., Beatty J.T., editors. Advances in Photosynthesis and Respiration. Dordrecht: Springer; 2009. [Google Scholar]
  • 39.Harada J, Mizoguchi T, Tsukatani Y, et al. A seventh bacterial chlorophyll driving a large light-harvesting antenna. Sci Rep. 2012;2:671. doi: 10.1038/srep00671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Brandis AS, Salomon Y, Scherz A. Bacteriochlorophyll Sensitizers in Photodynamic Therapy. In: Grimm B. PRJ, Rüdiger W., Scheer H., editors. Chlorophylls and Bacteriochlorophylls Advances in Photosynthesis and Respiration. Dordrecht: Springer; 2006. pp. 485–494. [Google Scholar]
  • 41.Limantara L, Koehler P, Wilhelm B, et al. Photostability of bacteriochlorophyll a and derivatives: potential sensitizers for photodynamic tumor therapy. Photochem Photobiol. 2006;82:770–780. doi: 10.1562/2005-09-07-RA-676. [DOI] [PubMed] [Google Scholar]
  • 42.Blankenship RE. Identification of a key step in the biosynthetic pathway of bacteriochlorophyll c and its implications for other known and unknown green sulfur bacteria. J Bacteriol. 2004;186:5187–5188. doi: 10.1128/JB.186.16.5187-5188.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Bryant N-UFGMCAMA. Chlorophylls and Bacteriochlorophylls. In: Grimm B. PRJ, Rüdiger W., Scheer H., editors. Advances in Photosynthesis and Respiration. Dordrecht: Springer; 2006. [Google Scholar]
  • 44.Choi SY, Yoon KH, Lee JI, et al. Violacein: properties and production of a versatile bacterial pigment. BioMed Res Int. 2014;2015:1–8. doi: 10.1155/2015/465056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.de Siqueira IC, Dias J, Ruf H, et al. Chromobacterium violaceum in siblings, Brazil. Emerg Infect Dis. 2005;11:1443–1445. doi: 10.3201/eid1109.050278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Konzen M, De Marco D, Cordova CA, et al. Antioxidant properties of violacein: possible relation on its biological function. Bioorg Med Chem. 2006;14:8307–8313. doi: 10.1016/j.bmc.2006.09.013. [DOI] [PubMed] [Google Scholar]
  • 47.Ferreira CV, Bos CL, Versteeg HH, et al. Molecular mechanism of violacein-mediated human leukemia cell death. Blood. 2004;104:1459–1464. doi: 10.1182/blood-2004-02-0594. [DOI] [PubMed] [Google Scholar]
  • 48.Matz C, Deines P, Boenigk J, et al. Impact of violacein-producing bacteria on survival and feeding of bacterivorous nanoflagellates. Appl Environ Microbiol. 2004;70:1593–1599. doi: 10.1128/AEM.70.3.1593-1599.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Choi SY, Yoon KH, Lee JI, et al. Violacein: properties and production of a versatile bacterial pigment. Biomed Res Int. 2015;2015:465056. doi: 10.1155/2015/465056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Fuller JJ, Ropke R, Krausze J, et al. Biosynthesis of violacein, structure and function of l-Tryptophan oxidase VioA from Chromobacterium violaceum. J Biol Chem. 2016;291:20068–20084. doi: 10.1074/jbc.M116.741561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Nakamura Y, Asada C, Sawada T. Production of antibacterial violet pigment by psychrotropic bacterium RT102 strain. Biotechnol Bioprocess Eng. 2003;8:37–40. [Google Scholar]
  • 52.Subramaniam S, Ravi V, Sivasubramanian A. Synergistic antimicrobial profiling of violacein with commercial antibiotics against pathogenic micro-organisms. Pharm Biol. 2014;52:86–90. doi: 10.3109/13880209.2013.815634. [DOI] [PubMed] [Google Scholar]
  • 53.Melo PS, Maria SS, Vidal BC, et al. Violacein cytotoxicity and induction of apoptosis in V79 cells. In Vitro Cell Dev Biol Anim. 2000;36:539–543. doi: 10.1290/1071-2690(2000)036<0539:vcaioa>2.0.co;2. [DOI] [PubMed] [Google Scholar]
  • 54.de Carvalho DD, Costa FT, Duran N, et al. Cytotoxic activity of violacein in human colon cancer cells. Toxicol In Vitro. 2006;20:1514–1521. doi: 10.1016/j.tiv.2006.06.007. [DOI] [PubMed] [Google Scholar]
  • 55.Bilsland E, Tavella TA, Krogh R, et al. Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons. BMC Biotechnol. 2018;18:22. doi: 10.1186/s12896-018-0428-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sakai-Kawada FE, Ip CG, Hagiwara KA, et al. Biosynthesis and bioactivity of prodiginine analogs in marine bacteria, pseudoalteromonas: a mini review. Front Microbiol. 2019;10:1715. doi: 10.3389/fmicb.2019.01715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Boric M, Danevcic T, Stopar D. Prodigiosin from Vibrio sp. DSM 14379; a new UV-protective pigment. Microb Ecol. 2011;62:528–536. doi: 10.1007/s00248-011-9857-0. [DOI] [PubMed] [Google Scholar]
  • 58.Nwankwo IU IV, Chidiebere OL, Nwachukwu MP. Evaluation of antimicrobial activity of prodigiosin produced from Serratia marcescens against some pathogenic bacteria. Futo J Series. 2017;3:93–102. [Google Scholar]
  • 59.Singh P, Shekhawat N. Chemometric descriptors in the rationale of antimalarial activity of natural and synthetic prodiginines. J Curr Chem Pharm Sci. 2012;2:224–260. [Google Scholar]
  • 60.Suryawanshi RK, Koujah L, Patil CD, et al. Bacterial pigment prodigiosin demonstrates a unique antiherpesvirus activity that is mediated through inhibition of prosurvival signal transducers. J Virol. 2020;94 doi: 10.1128/JVI.00251-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Darshan N, Manonmani HK. Prodigiosin and its potential applications. J Food Sci Technol. 2015;52:5393–5407. doi: 10.1007/s13197-015-1740-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Gristwood T, McNeil MB, Clulow JS, et al. PigS and PigP regulate prodigiosin biosynthesis in Serratia via differential control of divergent operons, which include predicted transporters of sulfur-containing molecules. J Bacteriol. 2011;193:1076–1085. doi: 10.1128/JB.00352-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Pandey R, Chander R, Sainis KB. Prodigiosins: a novel family of immunosuppressants with anti-cancer activity. Indian J Biochem Biophys. 2007;44:295–302. [PubMed] [Google Scholar]
  • 64.Montaner B, Perez-Tomas R. Prodigiosin-induced apoptosis in human colon cancer cells. Life Sci. 2001;68:2025–2036. doi: 10.1016/s0024-3205(01)01002-5. [DOI] [PubMed] [Google Scholar]
  • 65.Kimyon O, Das T, Ibugo AI, et al. Serratia secondary metabolite prodigiosin inhibits Pseudomonas aeruginosa biofilm development by producing reactive oxygen species that damage biological molecules. Front Microbiol. 2016;7:972. doi: 10.3389/fmicb.2016.00972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Van Dien SJ, Marx CJ, O'Brien BN, et al. Genetic characterization of the carotenoid biosynthetic pathway in Methylobacterium extorquens AM1 and isolation of a colorless mutant. Appl Environ Microbiol. 2003;69:7563–7566. doi: 10.1128/AEM.69.12.7563-7566.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Frengova GI, Beshkova DM. Carotenoids from Rhodotorula and Phaffia: yeasts of biotechnological importance. J Ind Microbiol Biotechnol. 2009;36:163–180. doi: 10.1007/s10295-008-0492-9. [DOI] [PubMed] [Google Scholar]
  • 68.Cooney JJ, Marks HW, Smith AM. Isolation and Identification of Canthaxanthin from Micrococcus roseus. J Bacteriol. 1966;92:342–345. doi: 10.1128/jb.92.2.342-345.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Miller NJ, Sampson J, Candeias LP, et al. Antioxidant activities of carotenes and xanthophylls. FEBS Lett. 1996;384:240–242. doi: 10.1016/0014-5793(96)00323-7. [DOI] [PubMed] [Google Scholar]
  • 70.Jagannadham MV, Chattopadhyay MK, Subbalakshmi C, et al. Carotenoids of an Antarctic psychrotolerant bacterium, Sphingobacterium antarcticus, and a mesophilic bacterium, Sphingobacterium multivorum. Arch Microbiol. 2000;173:418–424. doi: 10.1007/s002030000163. [DOI] [PubMed] [Google Scholar]
  • 71.Liu GY, Essex A, Buchanan JT, et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med. 2005;202:209–215. doi: 10.1084/jem.20050846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Rajagopal L, Sundari CS, Balasubramanian D, et al. The bacterial pigment xanthomonadin offers protection against photodamage. FEBS Lett. 1997;415:125–128. doi: 10.1016/s0014-5793(97)01109-5. [DOI] [PubMed] [Google Scholar]
  • 73.Dieser M, Greenwood M, Foreman CM. Carotenoid pigmentation in Antarctic hetero-trophic bacteria as a strategy to withstand environmental stresses. Arct Antarct Alp Res. 2010;42:396–405. [Google Scholar]
  • 74.Koyyati R, Kudle KR, Padigya PRM. Antibacterial, antioxidant and cytotoxic activity of bacterial carotenoids isolated from Rhodopseudomonas palustris KRPR01 and KRPR02. Int J Pharm Sci Res. 2019;10:4644–4649. [Google Scholar]
  • 75.Ravikumar S UG, Gokulakrishnan R. Antibacterial property of Halobacterial carotenoids against human bacterial pathogens. J Sci Ind (India) 2016;75:253–257. [Google Scholar]
  • 76.Paniagua-Michel J, Olmos-Soto J, Ruiz MA. Pathways of carotenoid biosynthesis in bacteria and microalgae. Methods Mol Biol. 2012;892:1–12. doi: 10.1007/978-1-61779-879-5_1. [DOI] [PubMed] [Google Scholar]
  • 77.Chew BP, Park JS. Carotenoid action on the immune response. J Nutr. 2004;134:257S–261S. doi: 10.1093/jn/134.1.257S. [DOI] [PubMed] [Google Scholar]
  • 78.Azman AS, Mawang CI, Abubakar S. Bacterial Pigments: The Bioactivities and as an Alternative for Therapeutic Applications. Nat Prod Commun. 2018;13:1747–1754. [Google Scholar]
  • 79.Reichenbach H, Kleinig H, Achenbach H. The pigments of Flexibacter elegans: Novel and chemosystematically useful compounds. Arch Microbiol. 1974;101:131–144. doi: 10.1007/BF00455933. [DOI] [PubMed] [Google Scholar]
  • 80.Ghosh A, Goyal A, Jain RK. Study of methanol-induced phenotypic changes in a novel strain of Acinetobacter lwoffii. Arch Microbiol. 2007;188:533–539. doi: 10.1007/s00203-007-0268-z. [DOI] [PubMed] [Google Scholar]
  • 81.Margalith PZ. Pigment Microbiology. London, UK: Chapman & Hall; 1992. Pigment Microbiology. [Google Scholar]
  • 82.Ivanov AG, Krol M, Selstam E, et al. The induction of CP43' by iron-stress in Synechococcus sp. PCC 7942 is associated with carotenoid accumulation and enhanced fatty acid unsaturation. Biochim Biophys Acta. 2007;1767:807–813. doi: 10.1016/j.bbabio.2007.02.006. [DOI] [PubMed] [Google Scholar]
  • 83.Howes CD, Batra PP. Accumulation of lycopene and inhibition of cyclic carotenoids in Mycobacterium in the presence of nicotine. Biochim Biophys Acta. 1970;222:174–179. doi: 10.1016/0304-4165(70)90362-4. [DOI] [PubMed] [Google Scholar]
  • 84.Saviola B, Felton J. Acidochromogenicity is a common characteristic in nontuberculous mycobacteria. BMC Res Notes. 2011;4:466. doi: 10.1186/1756-0500-4-466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Saviola B. Pigments and pathogenesis. J Mycobact Dis. 2014;4:1–3. [Google Scholar]
  • 86.Coyne VE, al-Harthi L. Induction of melanin biosynthesis in Vibrio cholerae. Appl Environ Microbiol. 1992;58:2861–2865. doi: 10.1128/aem.58.9.2861-2865.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Euseby J. List of prokaryotic names with standing in nomenclature. 1997.
  • 88.Runyon EH. Pigment variations in photochromogenic mycobacteria with special reference to M. vaccae. Pneumonologie. 1970;142:90–93. doi: 10.1007/BF02095201. [DOI] [PubMed] [Google Scholar]
  • 89.Robledo JA, Murillo AM, Rouzaud F. Physiological role and potential clinical interest of mycobacterial pigments. IUBMB Life. 2011;63:71–78. doi: 10.1002/iub.424. [DOI] [PubMed] [Google Scholar]
  • 90.Tarnok I, Tarnok Z. Carotene and xanthophylls in mycobacteria. I. Technical procedures; thin-layer chromatographic patterns of mycobacterial pigments. Tubercle. 1970;51:305–312. doi: 10.1016/0041-3879(70)90024-3. [DOI] [PubMed] [Google Scholar]
  • 91.Ramakrishnan L, Tran HT, Federspiel NA, et al. A crtB homolog essential for photochromogenicity in Mycobacterium marinum: isolation, characterization, and gene disruption via homologous recombination. J Bacteriol. 1997;179:5862–5868. doi: 10.1128/jb.179.18.5862-5868.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Provvedi R, Kocincova D, Dona V, et al. SigF controls carotenoid pigment production and affects transformation efficiency and hydrogen peroxide sensitivity in Mycobacterium smegmatis. J Bacteriol. 2008;190:7859–7863. doi: 10.1128/JB.00714-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Singh AK, Dutta D, Singh V, et al. Characterization of Mycobacterium smegmatis sigF mutant and its regulon: overexpression of SigF antagonist (MSMEG_1803) in M. smegmatis mimics sigF mutant phenotype, loss of pigmentation, and sensitivity to oxidative stress. Microbiologyopen. 2015;4:896–916. doi: 10.1002/mbo3.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am. 1959;43:273–290. doi: 10.1016/s0025-7125(16)34193-1. [DOI] [PubMed] [Google Scholar]
  • 95.Koh WJ, Kwon OJ, Lee KS. Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients. Korean J Radiol. 2002;3:145–157. doi: 10.3348/kjr.2002.3.3.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Kiehn TE, Edwards FF, Brannon P, et al. Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol. 1985;21:168–173. doi: 10.1128/jcm.21.2.168-173.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.van Ingen J, Turenne CY, Tortoli E, et al. A definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review. Int J Syst Evol Microbiol. 2018;68:3666–3677. doi: 10.1099/ijsem.0.003026. [DOI] [PubMed] [Google Scholar]
  • 98.Honda JR, Hasan NA, Davidson RM, et al. Environmental Nontuberculous Mycobacteria in the Hawaiian Islands. PLoS Negl Trop Dis. 2016;10:e0005068. doi: 10.1371/journal.pntd.0005068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Falkinham JO, Williams MD, Kwait R, et al. Methylobacterium spp. as an indicator for the presence or absence of Mycobacterium spp. Int J Mycobacteriol. 2016;5:240–243. doi: 10.1016/j.ijmyco.2016.03.001. [DOI] [PubMed] [Google Scholar]
  • 100.Garcia-Coca M, Rodriguez-Sevilla G, Perez-Domingo A, et al. Inhibition of Mycobacterium abscessus, M. chelonae, and M. fortuitum biofilms by Methylobacterium sp. J Antibiot (Tokyo) 2020;73:40–47. doi: 10.1038/s41429-019-0232-6. [DOI] [PubMed] [Google Scholar]
  • 101.Frehel C, Ryter A, Rastogi N, et al. The electron-transparent zone in phagocytized Mycobacterium avium and other mycobacteria: formation, persistence and role in bacterial survival. Ann Inst Pasteur Microbiol. 1986;137B:239–257. doi: 10.1016/s0769-2609(86)80115-6. [DOI] [PubMed] [Google Scholar]
  • 102.Gordon RE, Pang CH. Black beauty out of Mycobacterium fortuitum Cruz. Appl Microbiol. 1970;19:862–864. doi: 10.1128/am.19.5.862-864.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Brown BA, Springer B, Steingrube VA, et al. Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol. 1999;49 Pt 4:1493–1511. doi: 10.1099/00207713-49-4-1493. [DOI] [PubMed] [Google Scholar]
  • 104.Maya-Hoyos M, Leguizamon J, Marino-Ramirez L, et al. Sliding motility, biofilm formation, and glycopeptidolipid production in Mycobacterium colombiense Strains. Biomed Res Int. 2015;2015:419549. doi: 10.1155/2015/419549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.McMullen AR, Mattar C, Kirmani N, et al. Brown-pigmented Mycobacterium mageritense as a cause of prosthetic valve endocarditis and bloodstream infection. J Clin Microbiol. 2015;53:2777–2780. doi: 10.1128/JCM.01041-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Hawkins JE, Falco EB. Mycobacterium resembling Mycobacterium fortuitum that produces brown pigment. J Clin Microbiol. 1976;3:453–455. doi: 10.1128/jcm.3.4.453-455.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Stormer RS, Falkinham JO. Differences in antimicrobial susceptibility of pigmented and unpigmented colonial variants of Mycobacterium avium. J Clin Microbiol. 1989;27:2459–2465. doi: 10.1128/jcm.27.11.2459-2465.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Falkinham JO. Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol. 2009;107:356–367. doi: 10.1111/j.1365-2672.2009.04161.x. [DOI] [PubMed] [Google Scholar]
  • 109.Falkinham JO. Ecology of nontuberculous mycobacteria-where do human infections come from? Semin Respir Crit Care Med. 2013;34:95–102. doi: 10.1055/s-0033-1333568. [DOI] [PubMed] [Google Scholar]
  • 110.Lipner EM, Knox D, French J, et al. A geospatial epidemiologic analysis of nontuberculous Mycobacterial infection: an ecological study in Colorado. Ann Am Thorac Soc. 2017;14:1523–1532. doi: 10.1513/AnnalsATS.201701-081OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Bodmer T, Miltner E, Bermudez LE. Mycobacterium avium resists exposure to the acidic conditions of the stomach. FEMS Microbiol Lett. 2000;182:45–49. doi: 10.1111/j.1574-6968.2000.tb08871.x. [DOI] [PubMed] [Google Scholar]
  • 112.Dawrs SN, Kautz M, Chan ED, et al. Mycobacterium abscessus and Gastroesophageal Reflux: An in vitro Study. Am J Respir Crit Care Med. 2020;202:466–469. doi: 10.1164/rccm.202001-0011LE. [DOI] [PubMed] [Google Scholar]
  • 113.Nikitushkin VD, Shleeva MO, Zinin AI, et al. The main pigment of the dormant Mycobacterium smegmatis is porphyrin. FEMS Microbiol Lett. 2016;363 doi: 10.1093/femsle/fnw206. [DOI] [PubMed] [Google Scholar]
  • 114.Garvey M. Mycobacterium avium subspecies paratuberculosis: A possible causative agent in human morbidity and risk to public health safety. Open Vet J. 2018;8:172–181. doi: 10.4314/ovj.v8i2.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.Nguyen Le T. An investigation of the expression of pigment genes in Mycobacterium avium subspecies paratuberculosis, strain K10: University of Nottingham. 2017.
  • 116.Liu CI, Liu GY, Song Y, et al. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science. 2008;319:1391–1394. doi: 10.1126/science.1153018. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from AIMS Microbiology are provided here courtesy of AIMS Press

RESOURCES